EI
CRDF icon

EAM Investors’s Cardiff Oncology CRDF Stock Holding History

EAM Investors’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-161,903
Closed -$865K – 271
2024
Q1 		$865K Buy
+161,903
New +$430K 0.13% 192
2021
Q1 		– Sell
-45,517
Closed -$819K – 359
2020
Q4 		$819K Sell
45,517
-287,383
-86% -$5.05M 0.13% 282
2020
Q3 		$4.72M Buy
332,900
+204,490
+159% +$1.35M 1.12% 3
2020
Q2 		$643K Buy
+128,410
New +$263K 0.14% 235
2015
Q3 		– Sell
-4,039
Closed -$2.95M – 303
2015
Q2 		$2.95M Buy
+4,039
New +$2.86M 0.35% 139
2013
Q4 		– Sell
-3,765
Closed -$1.95M – 318
2013
Q3 		$1.95M Buy
3,765
+1,129
+43% +$643K 0.39% 73
2013
Q2 		$1.33M Buy
+2,636
New +$1.19M 0.29% 124

Other funds holding CRDF

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BC
BIT Capital Berlin, Germany $3.38B AUM 214.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

EAM Investors's CRDF Position: Q2 2024 in Review

EAM Investors sold out of Cardiff Oncology (CRDF) in Q2 2024, closing a stake of 161,903 shares — an estimated $865K sold.

EAM Investors first reported a position in CRDF in Q2 2013 and held it in 7 quarters. The position peaked at $4.72M in Q3 2020. 90 funds tracked by Wall St. Rank hold CRDF as of Q2 2024.

  • EAM Investors reported no remaining Cardiff Oncology position as of Q2 2024 after selling out during the quarter.
  • EAM Investors sold 161,903 Cardiff Oncology shares in Q2 2024, an estimated $865K.
  • EAM Investors first reported a position in Cardiff Oncology in Q2 2013 and held it in 7 quarters.
  • EAM Investors's Cardiff Oncology position peaked at $4.72M in Q3 2020.
  • 90 funds tracked by Wall St. Rank held Cardiff Oncology as of Q2 2024.

Based on EAM Investors's 13F filing for Q2 2024, filed 12 Aug 2024.